Despite 10 Percent Decline in Q1 Revenues, Waters CEO Sees Rays of Light for Second Half of 2009 | GenomeWeb

This story originally ran on April 28.

In the midst of reporting a 10 percent drop in revenues for the first quarter, Waters officials sounded a guarded note that the second half of 2009 could hold reasons for hope.

This week, Waters said that revenues for the three months ended April 4 fell to $333 million from $372 million during Q1 2008. Currency translation contributed 5 percentage points of the total drop in revenues.

Instrument sales were down by 16 percent in the quarter, while consumables and services rose 9 percent.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.